Literature DB >> 8386872

Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system.

J Dong1, E Hunter.   

Abstract

The nature of protein-protein interactions during retroviral assembly is not well understood, and mutational analyses of the potential signals involved in the viral assembly process has been difficult, particularly with the avian retroviruses due to the level of viral proteins expressed in the clonal cell lines containing defective viral genomes. We describe here a complementation system in which the retroviral gag/pol and env gene products were expressed independently from different plasmids under the control of the bacteriophage T7 promoter, in avian cells. Coexpression of the T7 polymerase from a vaccinia virus vector resulted in a high level of biosynthesis of retroviral structural proteins and efficient assembly of virus particles. Electron microscopy and protein composition analyses demonstrated that these virions were indistinguishable from those produced from RSV-infected cells. Through the use of mutant glycoprotein genes it was possible to demonstrate the specificity of the assembly process and the applicability of this system to other retroviral systems is described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386872     DOI: 10.1006/viro.1993.1249

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  The M2 ectodomain is important for its incorporation into influenza A virions.

Authors:  E K Park; M R Castrucci; A Portner; Y Kawaoka
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.

Authors:  N Savard; F L Cosset; A L Epstein
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.

Authors:  S Valsesia-Wittmann; A Drynda; G Deléage; M Aumailley; J M Heard; O Danos; G Verdier; F L Cosset
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.

Authors:  X Wu; J A Conway; J Kim; J C Kappes
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.

Authors:  P Spearman; J J Wang; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.

Authors:  X Wu; H Liu; H Xiao; J Kim; P Seshaiah; G Natsoulis; J D Boeke; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 7.  Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections.

Authors:  Magdalena Figlerowicz; Magdalena Alejska; Anna Kurzyńska-Kokorniak; Marek Figlerowicz
Journal:  Med Res Rev       Date:  2003-07       Impact factor: 12.944

8.  Retention of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum does not redirect virus assembly from the plasma membrane.

Authors:  K Salzwedel; J T West; M J Mulligan; E Hunter
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.

Authors:  S Sandefur; V Varthakavi; P Spearman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.